IFNA1 and systemic lupus erythematosus: In particular, patients with systemic lupus erythematosus (SLE) have increased serum activity of IFN-α and excessive signatures of interferon-stimulated genes (ISGs) in peripheral blood leukocytes (Blanco and others 2001; Bennett and others 2003).